Patient Reported Outcomes With Fingolimod in Local Experience (PROFILE)

Trial Profile

Patient Reported Outcomes With Fingolimod in Local Experience (PROFILE)

Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2017

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms PROFILE
  • Sponsors Novartis
  • Most Recent Events

    • 12 Oct 2017 Interim results of 3 month comparing satisfaction with previous treatment and fingolimod at three months, presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
    • 24 May 2017 Status changed from recruiting to completed.
    • 21 Oct 2015 Planned End Date changed from 1 Jan 2016 to 1 Dec 2016 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top